Search Results - ioulia+chatzistamou

4 Results

Sort By:

Anti-CCL8 Antibodies for COVID-19 and Other Immune Related Conditions

Reference #: 01487 The University of South Carolina is offering licensing opportunities for Anti-CCL8 Antibodies for COVID-19 and Other Immune Related Conditions Background: CCL8 (MCP-2) is a chemo attractive cytokine that is involved in the pathogenesis of various pathologies including cancer, autoimmune disorders, graft versus host disease and...

Published: 9/16/2024 | Inventor(s): Hippokratis Kiaris, Asieh Naderi, Ioulia Chatzistamou

Keywords(s): ARDS, CCL8, COVID-19

Category(s): Health Sciences, Biomedical and Life Sciences

A Gene to Transcriptome Association Platform for Drug Target Identification

Reference #: 01465 The University of South Carolina is offering licensing opportunities for A Gene to Transcriptome Association platform for drug target identification Background: Data accumulation through genomic and transcriptomic analyses require novel tools/strategies for the extraction of biologically relevant and clinically useful information....

Published: 5/22/2024 | Inventor(s): Ioulia Chatzistamou, Hippokratis Kiaris, Youwen Zhang

Keywords(s): AI, artificial intelligence, drug discovery, target identification

Category(s): Health Sciences, Biomedical and Life Sciences

Growth Of Human Cancers In Peromyscus

Reference #: 01211The University of South Carolina is offering licensing opportunities for an experimental methodology that allows growth of transplantable human tumors on appropriate subjects and can be tested with results that mimic drug tests in naturally existing populationsInvention Description: The subject invention is a protocol that allows growth...

Published: 9/26/2023 | Inventor(s): Hippokratis Kiaris, Ioulia Chatzistamou, Eleni Farmaki, Vimala Kaza

Keywords(s):

Category(s): Biomedical and Life Sciences, Chemistry and Biochemistry, Health Sciences

Anti-diabetic Activity of Ciclopirox

Reference #: 01154 The University of South Carolina is offering licensing opportunities for using Ciclopirox to treat diabetes and other conditions that involve the loss of glucose homeostasis.Invention Description: The subject invention is a novel use of Ciclopirox (also known as CPX, Loprox, or Ciclodan), an antibiotic used for fungal infections,...

Published: 5/27/2021 | Inventor(s): Hippokratis Kiaris, Ioulia Chatzistamou, Chrysovalantou Mihailidou

Keywords(s):

Category(s): Biomedical and Life Sciences, Health Sciences